FTC Takes Action Against Pharmacies Inflating Insulin Prices (Washington, DC) -- The three biggest pharmacy benefit managers are being accused of artificially inflating insulin prices. The FCC says ...

A dark money anti-pharma bus —A rare disease treatment approval for Zevra —An FTC lawsuit against pharmacy benefit managers ...

Reuters reported that the court did not address the merits of the case, only that a Texas judge was wrong to dismiss it in February. Meanwhile, the Federal Trade Commission has accused the three ...

"Millions of Americans with diabetes need insulin to survive, yet for many of these vulnerable patients, their insulin drug ...

The FTC’s complaint accuses Optum Rx and other pharmacy benefit managers of “abusing their economic power." Optum called the ...

We asked the candidates for Iowa's 1st Congressional District about abortion, the border, inflation, the Farm Bill and more.

The US Federal Trade Commission said that CVS Health's Caremark, Cigna's Express Scripts, and UnitedHealth Group's Optum ...

Novo Nordisk's chief executive is preparing for a showdown next week with U.S. Senator Bernie Sanders over the high price of ...

The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies ...

FTC Sues Prescription Drug Middlemen for Artificially Inflating Insulin Drug Prices – Includes Caremark, Express Scripts, ...

This summary highlights major health news, including EU's endorsement of Novo Nordisk's Wegovy for heart conditions in ...

The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially ...